SCHEMBL29270739

SCHEMBL29270739

C#CCC(C)(C)c1nnc(-c2cc3c(cc2F)SC[C@H](CC(C)(C)NC(=O)O)C(=O)N3)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29270822 0.91 PLAT (0.30) —
SCHEMBL26961708 0.80 GAA (0.32) —
SCHEMBL29796818 0.80 GAA (0.32) —
SCHEMBL29270801 0.78 LMNA (0.35) —
SCHEMBL29270757 0.78 CYP2C9 (0.33) —
SCHEMBL29270820 0.76 HDAC1 (0.33) —
SCHEMBL29270754 0.76 AKR1B1 (0.32) —
SCHEMBL29270708 0.75 TP53 (0.34) —
SCHEMBL29270721 0.71 CNR2 (0.32) —
SCHEMBL29270724 0.70 SSTR4 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116964048-A Bicyclic tetrahydroazepine derivatives for the treatment of cancer 豪夫迈·罗氏有限公司 2023-10-27 — — CN disclosed
Send feedback